- Report
- October 2024
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- August 2022
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP
The Collagen Meniscus Implant (CMI) is a type of orthopedic device used to treat meniscus tears in the knee. It is a minimally invasive procedure that involves implanting a collagen-based scaffold into the knee joint to replace the damaged meniscus. The implant is designed to provide support and stability to the knee joint, while also allowing for natural movement. The CMI is a relatively new technology, and is gaining popularity as an alternative to traditional meniscus repair surgery.
The CMI market is expected to grow in the coming years due to the increasing prevalence of knee injuries and the growing demand for minimally invasive treatments. The CMI is also seen as a cost-effective solution for treating meniscus tears, as it does not require the use of expensive implants or long recovery times.
Some of the major players in the CMI market include Zimmer Biomet, Smith & Nephew, Conmed Corporation, and Arthrex. Show Less Read more